Praxis Precision Medicines, Inc.: shareholders and insiders

PRAXNASDAQHealthcare · Pharmaceutical Preparations

Price

$300.43

November 20, 2026Market cap $8.4B

What Ploutos Investor adds for Praxis Precision Medicines

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Nov 18, 2026, from their own Form 4 filings.

14 Form 4s

Bought on the market

–

nobody

Sold on the market

$3.6M

1 person

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan100%
  • The rest0%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $3.6M by 1 person

  • 2025: no buys, no sales
  • 2026: no buys, sold $3.6M by 1 person
  • Nov 13, 2026Megan SniecinskiChief Operating Officer
    Kind
  • Nov 13, 2026Alex NemiroffGeneral Counsel and Secretary
    Kind
  • Nov 13, 2026Timothy Edwin KellyChief Financial Officer
    Kind
  • Nov 13, 2026Lauren MastrocolaPrincipal Accounting Officer
    Kind
  • Jul 8, 2026Marcio SouzaChief Executive Officer
    Kind
  • Jul 8, 2026Marcio SouzaChief Executive Officer
    Kind
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 24, 2026Jill DeSimoneDirector
    Kind10b5-1
  • Jun 10, 2026Stuart A ArbuckleDirector
    Kind
  • Jun 10, 2026Jeffrey ChodakewitzDirector
    Kind
  • Jun 10, 2026William D YoungDirector
    Kind
  • Jun 10, 2026Jill DeSimoneDirector
    Kind
  • Jun 10, 2026Merit Ester CudkowiczDirector
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by PRAX's officers and directors from 2020 up to November 21, 2025, 6 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

6 Holders over 5%Nov 5, 2026 Latest filing
  • Janus Henderson Groupwith 1 more person
    Share of class12.3%
  • FMRwith 1 more person
    Share of class9.20%
  • Perceptive Advisors LLCwith 2 more persons
    Share of class7.20%
  • Baker Bros. Advisors LPwith 3 more persons
    Share of class6.30%
  • Orbis Investment Managementwith 1 more person
    Share of class5.50%
  • Vanguard Capital Management
    Share of class5.09%
Fell to 5% or less (9)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Point72 Asset Management, L.P.0.20%May 15, 202613G/A
  • The Vanguard Group0.00%Mar 27, 202613G/A
  • Adage Capital Management, L.P.3.83%Feb 12, 202613G/A
  • Cormorant Asset Management, LP4.00%Nov 14, 202513G/A
  • T. Rowe Price Associates, Inc.4.80%Nov 14, 202513G/A
  • Morgan Stanley2.90%Nov 7, 202513G/A
  • Soleus Capital Master Fund, L.P.4.60%Aug 5, 202513G/A
  • Venrock Healthcare Capital Partners III, L.P.4.90%May 15, 202513G/A
  • Capital Research Global Investors4.20%May 13, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter+188%
  • Millennium Mgmt (Englander)
    In the quarter+638%
  • D.E. Shaw
    In the quarter+55%
  • AQR Capital
    In the quarter-3.5%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 14.1% of its shares outstanding were held short, -6.4% since the report before.

Shares held short
3.92M
14.1%
Since the report before4.19M on Sep 30, 2026
-6.4%
7.4
529.1K
More days to cover thanof 4,578 US-listed companies with enough volume
80%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 2.76M
  • Nov 15, 2023: Shares held short 3.46M
  • Nov 30, 2023: Shares held short 198.7K
  • Dec 15, 2023: Shares held short 235.5K
  • Dec 29, 2023: Shares held short 371.0K
  • Jan 12, 2024: Shares held short 486.7K
  • Jan 31, 2024: Shares held short 564.0K
  • Feb 15, 2024: Shares held short 348.9K
  • Feb 29, 2024: Shares held short 414.8K
  • Mar 15, 2024: Shares held short 409.3K
  • Mar 28, 2024: Shares held short 431.4K
  • Apr 15, 2024: Shares held short 763.9K
  • Apr 30, 2024: Shares held short 824.4K
  • May 15, 2024: Shares held short 844.9K
  • May 31, 2024: Shares held short 702.2K
  • Jun 14, 2024: Shares held short 865.3K
  • Jun 28, 2024: Shares held short 1.41M
  • Jul 15, 2024: Shares held short 1.59M
  • Jul 31, 2024: Shares held short 1.89M
  • Aug 15, 2024: Shares held short 1.86M
  • Aug 30, 2024: Shares held short 1.94M
  • Sep 13, 2024: Shares held short 1.90M
  • Sep 30, 2024: Shares held short 1.80M
  • Oct 15, 2024: Shares held short 1.72M
  • Oct 31, 2024: Shares held short 1.72M
  • Nov 15, 2024: Shares held short 1.53M
  • Nov 29, 2024: Shares held short 1.47M
  • Dec 13, 2024: Shares held short 1.53M
  • Dec 31, 2024: Shares held short 1.90M
  • Jan 15, 2025: Shares held short 2.04M
  • Jan 31, 2025: Shares held short 2.62M
  • Feb 14, 2025: Shares held short 2.67M
  • Feb 28, 2025: Shares held short 1.82M
  • Mar 14, 2025: Shares held short 2.06M
  • Mar 31, 2025: Shares held short 1.99M
  • Apr 15, 2025: Shares held short 1.85M
  • Apr 30, 2025: Shares held short 1.77M
  • May 15, 2025: Shares held short 1.88M
  • May 30, 2025: Shares held short 1.80M
  • Jun 13, 2025: Shares held short 1.74M
  • Jun 30, 2025: Shares held short 1.78M
  • Jul 15, 2025: Shares held short 1.94M
  • Jul 31, 2025: Shares held short 2.12M
  • Aug 15, 2025: Shares held short 2.33M
  • Aug 29, 2025: Shares held short 2.36M
  • Sep 15, 2025: Shares held short 2.38M
  • Sep 30, 2025: Shares held short 2.64M
  • Oct 15, 2025: Shares held short 2.61M
  • Oct 31, 2025: Shares held short 3.06M
  • Nov 14, 2025: Shares held short 3.61M
  • Nov 28, 2025: Shares held short 3.55M
  • Dec 15, 2025: Shares held short 3.67M
  • Dec 31, 2025: Shares held short 3.76M
  • Jan 15, 2026: Shares held short 3.75M
  • Jan 30, 2026: Shares held short 3.86M
  • Feb 13, 2026: Shares held short 3.80M
  • Feb 27, 2026: Shares held short 3.79M
  • Mar 13, 2026: Shares held short 3.74M
  • Mar 31, 2026: Shares held short 3.95M
  • Apr 15, 2026: Shares held short 3.78M
  • Apr 30, 2026: Shares held short 3.78M
  • May 15, 2026: Shares held short 3.71M
  • May 29, 2026: Shares held short 3.65M
  • Jun 15, 2026: Shares held short 3.57M
  • Jun 30, 2026: Shares held short 3.99M
  • Jul 15, 2026: Shares held short 3.76M
  • Jul 31, 2026: Shares held short 3.66M
  • Aug 14, 2026: Shares held short 3.71M
  • Aug 31, 2026: Shares held short 3.74M
  • Sep 15, 2026: Shares held short 3.80M
  • Sep 30, 2026: Shares held short 4.19M
  • Oct 15, 2026: Shares held short 3.92M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading50.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 50.5% of the shares in the reported trades were short sales, against 63.0% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
50.5%
The 14 beforeOct 14, 2026 – Nov 2, 2026
63.0%
Change
-12.5 pts
Short sales a dayon average, of 250.8K shares
126.6K
More than atof 3,666 US-listed companies, same days
50%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 28.3%
  • Oct 15, 2026: Short sales 56.5%
  • Oct 16, 2026: Short sales 71.4%
  • Oct 19, 2026: Short sales 68.7%
  • Oct 20, 2026: Short sales 73.6%
  • Oct 21, 2026: Short sales 65.6%
  • Oct 22, 2026: Short sales 72.3%
  • Oct 23, 2026: Short sales 54.8%
  • Oct 26, 2026: Short sales 84.8%
  • Oct 27, 2026: Short sales 78.6%
  • Oct 28, 2026: Short sales 72.7%
  • Oct 29, 2026: Short sales 80.8%
  • Oct 30, 2026: Short sales 58.6%
  • Nov 2, 2026: Short sales 60.2%
  • Nov 3, 2026: Short sales 73.2%
  • Nov 4, 2026: Short sales 73.8%
  • Nov 5, 2026: Short sales 62.7%
  • Nov 6, 2026: Short sales 40.4%
  • Nov 9, 2026: Short sales 42.4%
  • Nov 10, 2026: Short sales 58.4%
  • Nov 11, 2026: Short sales 58.3%
  • Nov 12, 2026: Short sales 41.9%
  • Nov 13, 2026: Short sales 52%
  • Nov 16, 2026: Short sales 44.4%
  • Nov 17, 2026: Short sales 42.7%
  • Nov 18, 2026: Short sales 36%
  • Nov 19, 2026: Short sales 57.9%
  • Nov 20, 2026: Short sales 66.5%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

2.28M Insiders' shares8.19% Of the company
  • Phillip GrossTenPercentOwner
    Directly–
  • Marcio SouzaChief Executive Officer
    Directly56.5K
  • Timothy Edwin KellyChief Financial Officer
    Directly31.2K
  • Megan SniecinskiChief Operating Officer
    Directly28.7K
  • Alex NemiroffGeneral Counsel and Secretary
    Directly26.1K
  • Dean J MitchellDirector
    Directly18.6K
  • Jill DeSimoneDirector
    Directly13.8K
  • Lauren MastrocolaPrincipal Accounting Officer
    Directly13.6K
  • William D YoungDirector
    Directly3,269
  • Stuart A ArbuckleDirector
    Directly2,537
  • Jeffrey B KindlerDirector
    Directly2,537
  • Gregory NordenDirector
    Directly1,559
  • Jeffrey ChodakewitzDirector
    Directly1,371
  • Merit Ester CudkowiczDirector
    Directly1,371

A lower bound: it counts only the 14 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

24 ETFs holding it1.29% The largest weight (XBI)
  • XBIState Street(R) SPDR(R) S&P(R) Biotech ETF
    Weight in the fund1.29%
  • LABUDirexion Daily S&P Biotech Bull 3X Shares
    Weight in the fund0.87%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.68%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.51%
  • FESMFidelity Enhanced Small Cap Core ETF
    Weight in the fund0.28%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.28%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.26%
  • VBRVanguard Small-Cap Value Index Fund
    Weight in the fund0.20%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.19%
  • VBVanguard Small-Cap Index Fund
    Weight in the fund0.11%

24 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

310 Managers, Q2 2026$11.3B Value of their positions
  • Q3 2025: Managers 153
  • Q4 2025: Managers 250
  • Q1 2026: Managers 293
  • Q2 2026: Managers 310

Institutional investors by quarter

The fund managers holding PRAX, quarter by quarter, from Q4 2020 to Q2 2025, 19 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 310 managers held 33.72M shares, worth $11.3B. During the quarter 59 opened a position, 42 closed one, 119 added and 93 trimmed.

The largest holders, Q2 2026

  • Jupiter Topco
    In the quarter
  • FMR
    In the quarter+7.2%
  • BlackRock
    In the quarter-1.4%
  • Perceptive Advisors
    In the quarter
  • Baker Bros. Advisors
    In the quarter
  • Orbis Allan Gray
    In the quarter-38%
  • Vanguard Portfolio Management
    In the quarter+76%
  • Vanguard Capital Management
    In the quarter+1.1%
  • State Street
    In the quarter+16%
  • Adage Capital Partners Gp
    In the quarter+24%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Praxis Precision Medicines's filings show?

Who buys and sells is one part of Praxis Precision Medicines's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about PRAX's shareholders

Didn't find what you were looking for?

Ask us
Have PRAX's insiders bought or sold?

From Jun 12, 2026 to Nov 18, 2026 Praxis Precision Medicines's insiders bought 0 and sold $3.6M of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold PRAX?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $16M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.